세계의 최소침습 수술 시장 규모, 점유율, 동향 분석 : 수술 분야별, 방법별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Minimally Invasive Surgery Market Trends:

The Minimally Invasive Surgery market size was valued at USD 486.72 billion in 2024 and is projected to reach USD 946.50 billion by 2033, growing at a CAGR of 7.82% from 2025 to 2033. The industry outlook is attributed to technological advancements, a growing geriatric population, and an increasing chronic disease burden. An important growth driver of minimally invasive surgery is the rising global surgical volume combined with a strong preference for less invasive approaches.

Minimally invasive surgeries have steadily increased over the years, becoming the preferred approach for many procedures due to their safety and faster recovery benefits. In July 2025, a research article noted that minimally invasive surgeries were linked with increased clinical outcomes, such as shorter hospital stays, fewer complications, and decreased recovery time. Furthermore, the report explains that when a hospital adopts the concept of MIS, the overall rate of minimally invasive surgery, such as laparoscopic or robotic, is likely to increase quickly, as both patients and surgeons prefer this method. These observations illustrate that the upward trajectory of surgical volumes, combined with the changing practice towards minimally invasive surgical techniques, is a large part of the current growth of this sector.

Minimally invasive surgery usage varies significantly between low- and middle-income countries (LMICs) and high-income countries (HICs). The main reasons are that the healthcare infrastructure, the surgical experts, and the resources are very different in these two. For example, in LMICs such as Uganda, Malaysia, and Vietnam, around 90% of MIS surgeries belong to the gynecology department, which includes uterine surgeries, appendectomy, and cholecystectomy. Those are the most common surgeries, and the local hospitals have the necessary instruments to perform them. Japan, Singapore, and the U.S. have fewer limitations on health care resources, and they can go a step further in the use of MIS for the various numbers of surgeries that they want to include in their operation profile, such as choledochal cyst excision and thoracic surgery that require not only the equipment but also the surgeon to train in that. The types of MIS procedures in different countries depend on healthcare resources and the system's maturity level.

Global Minimally Invasive Surgery Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Minimally Invasive Surgery (MIS) market report on the basis of surgical specialty, method, end use, and region:

• Surgical Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Gastrointestinal Surgery
• Gynecological Surgery
• Urological Surgery
• Cardiothoracic Surgery
• Orthopedic & Spine Surgery
• Neurosurgery
• Colorectal Surgery
• Bariatric Surgery
• Vascular & Endoscopic Surgery
• Plastic & Reconstructive Surgery
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Laparoscopic Surgery
• Thoracoscopic Surgery/VATS
• Robotic-assisted Surgery
• Endoscopic Surgery
• Catheter-based/Interventional Procedures
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Kuwait
  • UAE
  • Saudi Arabia
  • Qatar
  • Oman
  • Rest of the Middle East
  • Rest of Africa

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Surgical Specialty
  • 1.1.2. Method
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Surgical Specialty outlook
  • 2.2.2. Method outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising surgical volumes and preference for MIS
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Expanding geriatric population and increasing chronic disease burden
    • 3.2.1.4. Growing healthcare awareness and accessibility
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High capital investment
    • 3.2.2.2. Lack of skilled surgeons and maintenance costs
    • 3.2.2.3. Reimbursement and infrastructure limitations in emerging markets
  • 3.2.3. Market Restraint Analysis
    • 3.2.3.1. Integration of artificial intelligence (AI) and machine learning (ML) in MIS
    • 3.2.3.2. Personalization and 3D printing of surgical instruments
    • 3.2.3.3. Reimbursement and infrastructure limitations in emerging markets
  • 3.2.4. Key Devices Used in Minimally Invasive Surgeries (MIS)
    • 3.2.4.1. Instruments
      • 3.2.4.1.1. Endoscopes & Laparoscopes
      • 3.2.4.1.2. Surgical Cameras
      • 3.2.4.1.3. Energy-Based Devices (e.g., Electrosurgical & Ultrasonic Devices)
      • 3.2.4.1.4. Sealing & Stapling Devices
      • 3.2.4.1.5. Suction & Irrigation Systems
      • 3.2.4.1.6. Tumor Localization Systems
      • 3.2.4.1.7. Ligation Clips & Dilators
      • 3.2.4.1.8. Specimen Retrieval Systems
      • 3.2.4.1.9. Magnetic Millirobots
    • 3.2.4.2. Capital Equipment
      • 3.2.4.2.1. Robotic Surgical Systems (e.g., da Vinci Surgical System)
      • 3.2.4.2.2. Inflation Devices (e.g., Insufflators)
      • 3.2.4.2.3. Monitoring & Visualization Devices (e.g., Fluorescence Imaging Systems, ICG systems)
      • 3.2.4.2.4. Surgical Access Devices
    • 3.2.4.3. Consumables
      • 3.2.4.3.1. Hemostatic Agents & Adhesive Sealants (e.g., Fibrin Glue, Hemostatic Powders)
      • 3.2.4.3.2. Ligation Clips (if single-use)
      • 3.2.4.3.3. Stapler Cartridges (if disposable)
      • 3.2.4.3.4. Single-Use Specimen Bags
      • 3.2.4.3.5. Disposable insufflation tubing or single-use trocars (depending on model)
  • 3.2.5. Adoption Rate of Digital Technologies in MIS (e.g. AI, IoT Devices, Cloud Platforms) (In a graph format)
  • 3.2.6. Case Study: AI-Guided Autonomous Camera System in Laparoscopic Surgery
  • 3.2.7. Advancements and Ethical Considerations in Minimally Invasive Surgery: Cybersecurity, Customization, and Postoperative Data Analytics
• 3.3. Minimally Invasive Surgery (MIS) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Movement Analysis
• 4.3. Minimally Invasive Surgery (MIS) Market by Surgical Specialty Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. General Surgery
  • 4.5.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Gastrointestinal Surgery
  • 4.6.1. Gastrointestinal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Gynecological Surgery
  • 4.7.1. Gynecological Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Urological Surgery
  • 4.8.1. Urological Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Cardiothoracic Surgery
  • 4.9.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Orthopedic & Spine Surgery
  • 4.10.1. Orthopedic & Spine Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Neurosurgery Surgery
  • 4.11.1. Neurosurgery Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Colorectal Surgery
  • 4.12.1. Colorectal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Bariatric Surgery
  • 4.13.1. Bariatric Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Vascular & Endovascular Surgery
  • 4.14.1. Vascular & Endovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.15. Plastic & Reconstructive Surgery
  • 4.15.1. Plastic & Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Minimally Invasive Surgery (MIS) Market: Method Movement Analysis
• 5.3. Minimally Invasive Surgery (MIS) Market by Method Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Laparoscopic Surgery
  • 5.5.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Thoracoscopic Surgery/VATS
  • 5.6.1. Thoracoscopic Surgery/VATS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Robotic-assisted Surgery
  • 5.7.1. Robotic-assisted Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Endoscopic Surgery
  • 5.8.1. Endoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Catheter-based/Interventional Surgery
  • 5.9.1. Catheter-based/Interventional Surgery Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Minimally Invasive Surgery (MIS) Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Minimally Invasive Surgery (MIS) Market: End Use Movement Analysis
• 6.3. Minimally Invasive Surgery (MIS) Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ambulatory Surgical Centers (ASCs)
  • 6.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Specialty Clinics
  • 6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Minimally Invasive Surgery (MIS) Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Minimally Invasive Surgery (MIS) Market Movement Analysis
• 7.3. Minimally Invasive Surgery (MIS) Market: Regional Estimates & Trend Analysis by Surgical Specialty, Method, and end use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Minimally Invasive Surgery (MIS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Medtronic plc
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Intuitive Surgical
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. CMR Surgical
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Smith & Nephew plc
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Renishaw
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Monteris Medical
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. PROCEPT BioRobotics
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. EndoQuest Robotics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Moon Surgical
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Asensus Surgical US, Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Olympus Corporation
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives